These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33773183)

  • 21. Advances in 3D Vascularized Tumor-on-a-Chip Technology.
    Jung S; Jo H; Hyung S; Jeon NL
    Adv Exp Med Biol; 2022; 1379():231-256. PubMed ID: 35760994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microfluidic 'brain-on chip' systems to supplement neurological practice: development, applications and considerations.
    Jarrah R; Nathani KR; Bhandarkar S; Ezeudu CS; Nguyen RT; Amare A; Aljameey UA; Jarrah SI; Bhandarkar AR; Fiani B
    Regen Med; 2023 May; 18(5):413-423. PubMed ID: 37125510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applications of Microfluidics and Organ-on-a-Chip in Cancer Research.
    Regmi S; Poudel C; Adhikari R; Luo KQ
    Biosensors (Basel); 2022 Jun; 12(7):. PubMed ID: 35884262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human organ chips for regenerative pharmacology.
    Goyal G; Belgur C; Ingber DE
    Pharmacol Res Perspect; 2024 Feb; 12(1):e01159. PubMed ID: 38149766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer Metastasis-on-a-Chip for Modeling Metastatic Cascade and Drug Screening.
    Brooks A; Zhang Y; Chen J; Zhao CX
    Adv Healthc Mater; 2024 Aug; 13(21):e2302436. PubMed ID: 38224141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug screening on digital microfluidics for cancer precision medicine.
    Zhai J; Liu Y; Ji W; Huang X; Wang P; Li Y; Li H; Wong AH; Zhou X; Chen P; Wang L; Yang N; Chen C; Chen H; Mak PI; Deng CX; Martins R; Yang M; Ho TY; Yi S; Yao H; Jia Y
    Nat Commun; 2024 May; 15(1):4363. PubMed ID: 38778087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microfluidic endothelium-on-a-chip development, from in vivo to in vitro experimental models.
    Bulboacă AE; Boarescu PM; Melincovici CS; Mihu CM
    Rom J Morphol Embryol; 2020; 61(1):15-23. PubMed ID: 32747891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Review of the Application of Body-on-a-Chip for Drug Test and Its Latest Trend of Incorporating Barrier Tissue.
    Jin H; Yu Y
    J Lab Autom; 2016 Oct; 21(5):615-24. PubMed ID: 26721822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy.
    Astolfi M; Péant B; Lateef MA; Rousset N; Kendall-Dupont J; Carmona E; Monet F; Saad F; Provencher D; Mes-Masson AM; Gervais T
    Lab Chip; 2016 Jan; 16(2):312-25. PubMed ID: 26659477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling Barrier Tissues In Vitro: Methods, Achievements, and Challenges.
    Sakolish CM; Esch MB; Hickman JJ; Shuler ML; Mahler GJ
    EBioMedicine; 2016 Mar; 5():30-9. PubMed ID: 27077109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On-chip investigation of cell-drug interactions.
    Zheng XT; Yu L; Li P; Dong H; Wang Y; Liu Y; Li CM
    Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1556-74. PubMed ID: 23428898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model.
    Liu W; Song J; Du X; Zhou Y; Li Y; Li R; Lyu L; He Y; Hao J; Ben J; Wang W; Shi H; Wang Q
    Acta Biomater; 2019 Jun; 91():195-208. PubMed ID: 31034948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microfluidics-based in vivo mimetic systems for the study of cellular biology.
    Kim D; Wu X; Young AT; Haynes CL
    Acc Chem Res; 2014 Apr; 47(4):1165-73. PubMed ID: 24555566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-Based Assays on Microfluidics for Drug Screening.
    Liu X; Zheng W; Jiang X
    ACS Sens; 2019 Jun; 4(6):1465-1475. PubMed ID: 31074263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progress of microfluidic technology for pharmaceutical analysis.
    Jia X; Yang X; Luo G; Liang Q
    J Pharm Biomed Anal; 2022 Feb; 209():114534. PubMed ID: 34929566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospectives and retrospectives of microfluidics devices and lab-on-A-chip emphasis on cancer.
    Venkatesalu S; Dilliyappan S; Satish Kumar A; Palaniyandi T; Baskar G; Ravi M; Sivaji A
    Clin Chim Acta; 2024 Jan; 552():117646. PubMed ID: 38000458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro Microfluidic Models for Neurodegenerative Disorders.
    Osaki T; Shin Y; Sivathanu V; Campisi M; Kamm RD
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 28881425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-on-a-chip platforms for assessing nanoparticle-based cancer therapy.
    Wang Y; Cuzzucoli F; Escobar A; Lu S; Liang L; Wang S
    Nanotechnology; 2018 Aug; 29(33):332001. PubMed ID: 29794338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microfabrication of human organs-on-chips.
    Huh D; Kim HJ; Fraser JP; Shea DE; Khan M; Bahinski A; Hamilton GA; Ingber DE
    Nat Protoc; 2013 Nov; 8(11):2135-57. PubMed ID: 24113786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Industrial lab-on-a-chip: design, applications and scale-up for drug discovery and delivery.
    Vladisavljević GT; Khalid N; Neves MA; Kuroiwa T; Nakajima M; Uemura K; Ichikawa S; Kobayashi I
    Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1626-63. PubMed ID: 23899864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.